Lorenz Vogt

Title: Lorenz Vogt: Innovator in Fibrin Matrix Production

Introduction

Lorenz Vogt is a notable inventor based in Baeretswil, Switzerland. He has made significant contributions to the field of biomedical engineering, particularly in the development of methods for producing fibrin matrices. His innovative work has the potential to impact various medical applications.

Latest Patents

Lorenz Vogt holds a patent for "Methods and kits for producing a fibrin matrix." This patent describes methods for creating a fibrin matrix that includes a fusion peptide. The process involves three components: a first component containing fibrinogen or a fibrinogen precursor, a second component with thrombin or a thrombin precursor, and a third component that contains the fusion peptide. The components are mixed to form a fibrin matrix with a covalently linked fusion peptide, all within a time frame of no more than five days.

Career Highlights

Lorenz Vogt is associated with Kuros Biosurgery AG, a company focused on innovative solutions in the field of surgery. His work at the company emphasizes the importance of developing advanced medical technologies that can enhance patient outcomes.

Collaborations

Throughout his career, Lorenz has collaborated with esteemed colleagues such as Alistair Simpson Irvine and Philippe Paul Saudan. These collaborations have contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Lorenz Vogt's contributions to the field of fibrin matrix production highlight his role as an innovator in biomedical engineering. His patent and work at Kuros Biosurgery AG demonstrate his commitment to advancing medical technology for improved patient care.